Lafayette father first in Colorado to receive newly approved pancreatic cancer drug

Lafayette father first in Colorado to receive newly approved pancreatic cancer drug

9News health

Key Points:

  • DENVER — A Lafayette father with stage 4 pancreatic cancer is believed to be the first patient in Colorado to receive a newly approved targeted therapy.
  • Colin Kiesel recently started taking Zenocutuza

Trending Business

Trending Technology

Trending Health